Learn about BYDUREON® BCiseTM including efficacy, safety, PK profile, and dosing, and available resources, including Important Safety Information.
http://www.bydureonhcp.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
1.5 seconds
16x16
32x32
64x64
AstraZeneca AB
Domains Administration
Vastra ●●●●●●●amnen 9
Sod●●●lje , 15185
SE
View this contact
AstraZeneca AB
Domains Administration
Vastra ●●●●●●●amnen 9
Sod●●●lje , 15185
SE
View this contact
AstraZeneca AB
Domains Administration
Vastra ●●●●●●●amnen 9
Sod●●●lje , 15185
SE
View this contact
BUY YOUR DOMAIN
14
YEARS
3
MONTHS
2
DAYS
CSC CORPORATE DOMAINS, INC.
WHOIS : whois.corporatedomains.com
REFERRED : http://www.cscglobal.com
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
104
SITE IP
52.84.237.82
LOAD TIME
1.451 sec
SCORE
6.2
BYDUREON® (exenatide extended-release) injectable suspension, 2 mg | Official HCP Site | bydureonhcp.com Reviews
https://bydureonhcp.com
Learn about BYDUREON® BCiseTM including efficacy, safety, PK profile, and dosing, and available resources, including Important Safety Information.
bydureonhcp.com
REMS
https://www.bydureonhcp.com/rems.html
Go to Patient Site. Our Type 2 Diabetes Portfolio. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. 3-Year Clinical Trial Results. 24-Week Clinical Trial Results. Access and Savings Card. Print label resize label. Risk Evaluation and Mitigation Strategy. The goals of the BYDUREON REMS are:.
BYDUREON® (exenatide extended-release for injectable suspension) | Clinical Efficacy
https://www.bydureonhcp.com/clinical-efficacy.html
Go to Patient Site. Our Type 2 Diabetes Portfolio. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. 3-Year Clinical Trial Results. 24-Week Clinical Trial Results. Access and Savings Card. Print label resize label. DURATION-3 Results Over 3 Years. DURATION-5 Results at 24 Weeks. BYDUREON is con...
BYDUREON® (exenatide extended-release for injectable suspension) | Dosing and Administration
https://www.bydureonhcp.com/dosing-and-administration.html
Go to Patient Site. Our Type 2 Diabetes Portfolio. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. 3-Year Clinical Trial Results. 24-Week Clinical Trial Results. Access and Savings Card. Print label resize label. Select a category or scroll to learn more. On the patient website. Protect BYDUR...
Official BYDUREON® (exenatide extended-release for injectable suspension) Healthcare Professional Website
https://www.bydureonhcp.com/home.html
Go to Patient Site. Our Type 2 Diabetes Portfolio. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. 3-Year Clinical Trial Results. 24-Week Clinical Trial Results. Access and Savings Card. Print label resize label. View DURATION-3 Study Design. Designed to be patient-friendly. Exenatide extende...
BYDUREON® (exenatide extended-release for injectable suspension) | Science of BYDUREON
https://www.bydureonhcp.com/science-of-bydureon.html
Go to Patient Site. Our Type 2 Diabetes Portfolio. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. Risk Evaluation and Mitigation Strategy (REMS). Prescribing Information including Boxed WARNING. Indication and Limitations of Use. 3-Year Clinical Trial Results. 24-Week Clinical Trial Results. Access and Savings Card. Print label resize label. Select a category or scroll to learn more. GLP-1 Is an Important Incretin Hormone.
TOTAL PAGES IN THIS WEBSITE
12
Saxagliptin 5 mg Plus Metformin IR Clinical Trial Data | KombiglyzeXR-HCP.com
https://www.kombiglyzexr-hcp.com/efficacy.html
US Health Care Professionals. Go to Patient Site. Our Type 2 Diabetes. Prescribing Information, including Boxed WARNING. Indication and Limitations of Use. Prescribing Information, including Boxed WARNING. WARNING FOR KOMBIGLYZE XR: LACTIC ACIDOSIS. US Full Prescribing Information including Boxed WARNING. About lactic acidosis, and Medication Guide. Laboratory abnormalities include low pH, increased anion gap, and elevated blood lactate. 5 mg saxagliptin metformin IR. 5 mg saxagliptin metformin IR. 5 mg ...
Site Map | SYMLIN® (pramlintide acetate) injection
https://www.symlinhcp.com/site-map.html
Prescribing Information including Boxed WARNING. Pramlintide acetate) injection is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. For US Health Care Professionals. Go to Patient Site. Our Type 2 Diabetes Portfolio. Explore our other treatment options. Exenatide extended-release) for injectable suspension. Prescribing Information including Boxed WARNING.
AstraZeneca Medications
https://www.astrazeneca-us.com/medicines/astrazeneca-medications
This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our use of these cookies. Find out more about how we use cookies and how to manage them by reading our cookie notice. AstraZeneca in the United States. AstraZeneca in the US. Improving access to care. Health and science innovation. Medical information for healthcare providers. Help affording your medicines. Prescribing Information including Boxed WARNING. Health care professional site.
Dosing and Administration | XigduoXR-hcp.com
https://www.xigduoxr-hcp.com/dosing.html
US Health Care Professionals. Go to Patient Site. XIGDUO XR (dapagliflozin/metformin HCl extended-release) tablets. Our Type 2 Diabetes Portfolio. Prescribing Information, including Boxed WARNING. Prescribing Information, including Boxed WARNING. Indication and Limitations of Use. Dapagliflozin 10 mg Metformin XR vs Metformin XR Alone. Dapagliflozin 5 mg Metformin XR vs Metformin XR Alone. Dapagliflozin as Add-On Therapy to Metformin. Dapagliflozin Metformin vs Glipizide Metformin. SCIENCE OF XIGDUO XR.
A1C Levels | Dapagliflozin as Add-On Therapy to Metformin
https://www.xigduoxr-hcp.com/clinical-efficacy/dapagliflozin-add-on.html
US Health Care Professionals. Go to Patient Site. XIGDUO XR (dapagliflozin/metformin HCl extended-release) tablets. Our Type 2 Diabetes Portfolio. Prescribing Information, including Boxed WARNING. Prescribing Information, including Boxed WARNING. Indication and Limitations of Use. Dapagliflozin 10 mg Metformin XR vs Metformin XR Alone. Dapagliflozin 5 mg Metformin XR vs Metformin XR Alone. Dapagliflozin as Add-On Therapy to Metformin. Dapagliflozin Metformin vs Glipizide Metformin. SCIENCE OF XIGDUO XR.
Type 2 Diabetes Dosing and Administration | SYMLIN® (pramlintide acetate) injection
https://www.symlinhcp.com/dosing-and-administration/type-2-diabetes.html
Prescribing Information including Boxed WARNING. Pramlintide acetate) injection is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. For US Health Care Professionals. Go to Patient Site. Our Type 2 Diabetes Portfolio. Explore our other treatment options. Exenatide extended-release) for injectable suspension. Prescribing Information including Boxed WARNING.
Type 1 Diabetes Results | SYMLIN® (pramlintide acetate) injection
https://www.symlinhcp.com/clinical-efficacy/type-1-diabetes.html
Prescribing Information including Boxed WARNING. Pramlintide acetate) injection is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. For US Health Care Professionals. Go to Patient Site. Our Type 2 Diabetes Portfolio. Explore our other treatment options. Exenatide extended-release) for injectable suspension. Prescribing Information including Boxed WARNING.
Safety Profile | SYMLIN® (pramlintide acetate) injection
https://www.symlinhcp.com/safety-profile.html
Prescribing Information including Boxed WARNING. Pramlintide acetate) injection is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. For US Health Care Professionals. Go to Patient Site. Our Type 2 Diabetes Portfolio. Explore our other treatment options. Exenatide extended-release) for injectable suspension. Prescribing Information including Boxed WARNING.
Science of SYMLIN | SYMLIN® (pramlintide acetate) injection
https://www.symlinhcp.com/science-of-symlin.html
Prescribing Information including Boxed WARNING. Pramlintide acetate) injection is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. For US Health Care Professionals. Go to Patient Site. Our Type 2 Diabetes Portfolio. Explore our other treatment options. Exenatide extended-release) for injectable suspension. Prescribing Information including Boxed WARNING.
TOTAL LINKS TO THIS WEBSITE
104
Select your BYDUREON® (exenatide extended-release) injectable suspension product │ BYDUREON BCise exenatide extended-release injectable suspension
Prescribing Information including Boxed WARNING. Prescribing Information including Boxed WARNING. Important Safety Information, Approved Uses, Prescribing Information including Boxed WARNING. Medication Guide , Instructions for Use. To help lower blood sugar in adults with type 2 diabetes along with diet and exercise who are not at goal with pills. BYDUREON is not recommended as the first medication to treat diabetes. BYDUREON is a long-acting form of the medication in BYETTA. BYDUREON BCise is not a sub...
Bydureon Attorney
Skip to primary content. Skip to secondary content. Proudly powered by WordPress.
Diabetes Alliance
This site is now operated by AstraZeneca (AZ), the manufacturers of Bydureon (exenatide) 2mg powder and solvent for prolonged-release suspension for injection. I confirm I am a patient in the Republic of Ireland currently being prescribed Bydureon. I accept and agree to the legal notice. This site is provided for information purposes only and is not intended to be, and should not be used as, a substitute for medical advice. Date of preparation: April 2016 963,206.011. AstraZeneca maintains this website.
Bydureon Class Action
Skip to primary content. Skip to secondary content. Proudly powered by WordPress.
bydureonclassactionlawsuit.com
Bydureon Class Action Lawsuit
Bydureon Class Action Lawsuit. Skip to primary content. Skip to secondary content. Bydureon Class Action Lawsuit. Bydureon Class Action Lawsuit. Proudly powered by WordPress.
BYDUREON® (exenatide extended-release) injectable suspension, 2 mg | Official HCP Site
Important Safety Information, Approved Uses, Prescribing Information including Boxed WARNING. Indication and Limitations of Use. Prescribing Information including Boxed WARNING. Prescribing Information including Boxed WARNING. Medication Guide for BYDUREON BCise. Medication Guide for BYDUREON. Instructions for Use for BYDUREON BCise. Instructions for Use for BYDUREON. INDICATION AND LIMITATIONS OF USE. Not recommended as first-line. Therapy for patients inadequately controlled on diet and exercise. In a ...
Index of /
Bydureon Lawsuit
Skip to primary content. Skip to secondary content. Proudly powered by WordPress.
Bydureon Lawyer
Skip to primary content. Skip to secondary content. Proudly powered by WordPress.
Bydureon Pancreatic Cancer
Skip to primary content. Skip to secondary content. Proudly powered by WordPress.
Bydureon Thyroid Cancer
Skip to primary content. Skip to secondary content. Proudly powered by WordPress.
